Your browser doesn't support javascript.
loading
Shp2 promotes liver cancer stem cell expansion by augmenting ß-catenin signaling and predicts chemotherapeutic response of patients.
Xiang, Daimin; Cheng, Zhuo; Liu, Hui; Wang, Xue; Han, Tao; Sun, Wen; Li, Xiaofeng; Yang, Wen; Chen, Cheng; Xia, Mingyang; Liu, Na; Yin, Shengyong; Jin, Guangzhi; Lee, Terence; Dong, Liwei; Hu, Heping; Wang, Hongyang; Ding, Jin.
Afiliación
  • Xiang D; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
  • Cheng Z; Nelson Institute of Environmental Medicine, New York University School of Medicine, New York, NY.
  • Liu H; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
  • Wang X; The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
  • Han T; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
  • Sun W; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
  • Li X; Department of Oncology, General Hospital of Shenyang Military Region, Shenyang, China.
  • Yang W; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
  • Chen C; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
  • Xia M; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
  • Liu N; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
  • Yin S; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
  • Jin G; Department of Hepatobiliary Medicine, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
  • Lee T; Department of General Surgery, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Dong L; Department of Pathology, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
  • Hu H; Department of Pathology, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Pokfulam, Hong Kong.
  • Wang H; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
  • Ding J; Department of Hepatobiliary Medicine, Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University, Shanghai, China.
Hepatology ; 65(5): 1566-1580, 2017 05.
Article en En | MEDLINE | ID: mdl-28059452

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Células Madre Neoplásicas / Carcinoma Hepatocelular / Beta Catenina / Proteína Tirosina Fosfatasa no Receptora Tipo 11 / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatology Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Células Madre Neoplásicas / Carcinoma Hepatocelular / Beta Catenina / Proteína Tirosina Fosfatasa no Receptora Tipo 11 / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatology Año: 2017 Tipo del documento: Article